# The RaDiCo information system for rare disease cohorts

**Authors:** Paul Landais, Sonia Gueguen, Annick Clement, Serge Amselem, Christine Bodemer, Christine Bodemer, Patrick Calvas, Nicolas Chassaing, Annick Clement, Christian Corpechot, Vincent Cottin, Estelle Escudier, Bruno Fautrel, Sophie Georgin-Lavialle, Laurence Heidet, Bénédicte Héron, Xavier Jeunemaître, Bertrand Knebelmann, Agnès Linglart, Bernard Maitre, Jean-Louis Mandel, Irène Netchine, Aude Servais, Savine Vicart

PMC · DOI: 10.1186/s13023-025-03629-z · Orphanet Journal of Rare Diseases · 2025-04-08

## TL;DR

RaDiCo is a secure, cloud-based platform for managing rare disease e-cohorts, enabling data sharing and analysis across France.

## Contribution

RaDiCo introduces a national, interoperable information system for rare disease cohorts compliant with GDPR and FAIR principles.

## Key findings

- RaDiCo hosts 13 e-cohorts covering 67 rare diseases with 8063 patients from 180 sites as of April 2024.
- The platform supports data standardization, quality monitoring, and secure data exchange for rare disease research.
- RaDiCo is compatible with the French National Health Data Hub and can be extended to European Reference Networks.

## Abstract

Rare diseases (RDs) clinical care and research face several challenges. Patients are dispersed over large geographic areas, their number per disease is limited, just like the number of researchers involved. Current databases as well as biological collections, when existing, are generally local, of modest size, incomplete, of uneven quality, heterogeneous in format and content, and rarely accessible or standardised to support interoperability. Most disease phenotypes are complex corresponding to multi-systemic conditions, with insufficient interdisciplinary cooperation. Thus emerged the need to generate, within a coordinated, mutualised, secure and interoperable framework, high-quality data from national or international RD cohorts, based on deep phenotyping, including molecular analysis data, notably genotypic. The RaDiCo program objective was to create, under the umbrella of Inserm, a national operational platform dedicated to the development of RD e-cohorts. Its Information System (IS) is presented here.

Constructed on the cloud computing principle, the RaDiCo platform was designed to promote mutualization and factorization of processes and services, for both clinical epidemiology support and IS. RaDiCo IS is based on an interoperability framework combining a unique RD identifier, data standardisation, FAIR principles, data exchange flows/processes and data security principles compliant with the European GDPR.

RaDiCo IS favours a secure, open-source web application in order to implement and manage online databases and give patients themselves the opportunity to collect their data. It ensures a continuous monitoring of data quality and consistency over time. RaDiCo IS proved to be efficient, currently hosting 13 e-cohorts, covering 67 distinct RDs. As of April 2024, 8063 patients were recruited from 180 specialised RD sites spread across the national territory.

The RaDiCo operational platform is equivalent to a national infrastructure. Its IS enables RD e-cohorts to be developed on a shared platform with no limit on size or number. Compliant with the GDPR, it is compatible with the French National Health Data Hub and can be extended to the RDs European Reference Networks (ERNs).

RaDiCo provides a robust IS, compatible with the French Data Hub and RDs ERNs, integrated on a RD platform that enables e-cohorts creation, monitoring and analysis.

The online version contains supplementary material available at 10.1186/s13023-025-03629-z.

## Full-text entities

- **Diseases:** RDs (MESH:D035583), RD (MESH:D000077733)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11980265/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11980265/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC11980265/full.md

---
Source: https://tomesphere.com/paper/PMC11980265